UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 08/2008, Volume 359, Issue 7, pp. 677 - 687
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Coronary heart disease | Ticlopidine - therapeutic use | Vasodilator Agents - therapeutic use | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Male | Angina Pectoris - etiology | Angina Pectoris - psychology | Angioplasty, Balloon, Coronary | Patient Satisfaction | Coronary Disease - complications | Female | Surveys and Questionnaires | Aspirin - therapeutic use | Isosorbide Dinitrate - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Stents | Adrenergic beta-Antagonists - therapeutic use | Angina Pectoris - drug therapy | Metoprolol - therapeutic use | Combined Modality Therapy | Angina Pectoris - therapy | Ticlopidine - analogs & derivatives | Amlodipine - therapeutic use | Cross-Over Studies | Coronary Disease - therapy | Quality of Life | Health Status | Transluminal angioplasty | Care and treatment | Health aspects | Unstable angina | Risk factors | Medical research | Cardiovascular disease | Heart attacks | Angina pectoris | Coronary vessels | Index Medicus | Abridged Index Medicus
Journal Article
AIDS (London), ISSN 0269-9370, 05/2020, Volume 34, Issue 6, pp. 949 - 952
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Virology | Rosuvastatin Calcium - therapeutic use | Cardiovascular Diseases - drug therapy | HIV Infections - epidemiology | Humans | Middle Aged | Rosuvastatin Calcium - adverse effects | Male | Drug Interactions | Aged, 80 and over | Aging | Cardiovascular Diseases - epidemiology | Female | Anti-Retroviral Agents - therapeutic use | Atorvastatin - adverse effects | Atorvastatin - therapeutic use | Amlodipine - adverse effects | Treatment Outcome | Piperazines - therapeutic use | Piperazines - adverse effects | Amlodipine - therapeutic use | Antiretroviral Therapy, Highly Active | Oxazines - adverse effects | Cardiovascular Agents - therapeutic use | Oxazines - therapeutic use | Heterocyclic Compounds, 3-Ring - adverse effects | Heterocyclic Compounds, 3-Ring - therapeutic use | HIV Infections - drug therapy | Aged | Darunavir - adverse effects | Pyridones - therapeutic use | Cardiovascular Agents - adverse effects | Darunavir - therapeutic use | Pyridones - adverse effects | Index Medicus | AIDS/HIV
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2014, Volume 370, Issue 1, pp. 13 - 22
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | General aspects | Renovascular diseases | Atherosclerosis (general aspects, experimental research) | Nephropathies. Renovascular diseases. Renal failure | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Blood and lymphatic vessels | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Hypertension - drug therapy | Male | Renal Insufficiency, Chronic - complications | Renal Artery | Treatment Failure | Cardiovascular Diseases - mortality | Female | Angioplasty, Balloon | Pyrroles - therapeutic use | Stents | Cardiovascular Diseases - etiology | Renal Artery Obstruction - drug therapy | Kaplan-Meier Estimate | Combined Modality Therapy | Antihypertensive Agents - therapeutic use | Amlodipine - therapeutic use | Renal Artery Obstruction - complications | Anticholesteremic Agents - therapeutic use | Hypertension - complications | Aged | Renal Artery Obstruction - therapy | Drug Combinations | Prevention | Evaluation | Care and treatment | Usage | Atherosclerosis | Therapeutics | Stent (Surgery) | Homeopathy | Materia medica and therapeutics | Hypertension | Myocardial infarction | Cerebral infarction | Stroke | Kidneys | Renal artery | Antihypertensives | Medical treatment | Clinical trials | Stenosis | Cardiovascular disease | Congestive heart failure | Renal insufficiency | Arteriosclerosis | Implants | Renal failure | Blood pressure | Kidney diseases | Geriatrics | Index Medicus | Abridged Index Medicus
Journal Article
4.
Full Text
Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients
The New England journal of medicine, ISSN 0028-4793, 12/2008, Volume 359, Issue 23, pp. 2417 - 2428
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | General aspects | Arterial hypertension. Arterial hypotension | Medical sciences | Blood and lymphatic vessels | Benzazepines - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Risk | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Drug Therapy, Combination | Hydrochlorothiazide - adverse effects | Double-Blind Method | Kaplan-Meier Estimate | Amlodipine - adverse effects | Antihypertensive Agents - therapeutic use | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Benzazepines - therapeutic use | Diuretics - therapeutic use | Aged | Hydrochlorothiazide - therapeutic use | Hypertension | Prevention | Care and treatment | Usage | Benazepril | Cardiovascular diseases | Health aspects | Comparative studies | Clinical trials | Pharmacology | Calcium | ACE inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
5.
Full Text
Tako-tsubo cardiomyopathy observed in a patient with sepsis and transient hyperthyroidism
Monaldi archives for chest disease, ISSN 1122-0643, 03/2009, Volume 72, Issue 1, pp. 33 - 36
Sepsis | Ventricular function | Tako-tsubo cardiomyopathy | Transient hyperthyroidism | Glucocorticoids - therapeutic use | Echocardiography | Hyperthyroidism - diagnosis | Humans | Middle Aged | Propranolol - therapeutic use | Antithyroid Agents - therapeutic use | Ofloxacin - therapeutic use | Hyperthyroidism - drug therapy | Sepsis - complications | Takotsubo Cardiomyopathy - diagnosis | Antihypertensive Agents - therapeutic use | Takotsubo Cardiomyopathy - complications | Amlodipine - therapeutic use | Anti-Bacterial Agents - therapeutic use | Sepsis - drug therapy | Methimazole - therapeutic use | Electrocardiography | Hyperthyroidism - complications | Female | Aspirin - therapeutic use | Ramipril - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Prednisone - therapeutic use | Index Medicus | transient hyperthyroidism | sepsis | ventricular function
Journal Article
Journal of hypertension, ISSN 0263-6352, 10/2014, Volume 32, Issue 10, pp. 2038 - 2044
Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Bisoprolol - therapeutic use | Humans | Middle Aged | Hypertension - drug therapy | Male | Biphenyl Compounds - therapeutic use | Hypertension - etiology | Young Adult | Furosemide - therapeutic use | Aldosterone - metabolism | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Amiloride - therapeutic use | Adult | Female | Blood Pressure - drug effects | Hypertrophy, Left Ventricular - drug therapy | Ramipril - therapeutic use | Drug Therapy, Combination | Spironolactone - therapeutic use | Blood Pressure Determination | Hypertrophy, Left Ventricular - etiology | Renin - blood | Amlodipine - therapeutic use | Mineralocorticoid Receptor Antagonists - therapeutic use | Adolescent | Diuretics - therapeutic use | Renin-Angiotensin System - drug effects | Tetrazoles - therapeutic use | Aged | Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 01/2004, Volume 291, Issue 3, pp. 309 - 316
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Angina Pectoris - physiopathology | Physical Exertion - physiology | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Male | Physical Exertion - drug effects | Myocardial Ischemia | Ranolazine | Exercise Test | Electrocardiography | Female | Drug Therapy, Combination | Acetanilides | Adrenergic beta-Antagonists - therapeutic use | Double-Blind Method | Nitroglycerin - therapeutic use | Angina Pectoris - drug therapy | Piperazines - therapeutic use | Amlodipine - therapeutic use | Cardiovascular Agents - therapeutic use | Atenolol - therapeutic use | Diltiazem - therapeutic use | Survival Analysis | Aged | Hemodynamics | Chronic Disease | Clinical trials | Angina pectoris | Drug testing | Medical treatment
Journal Article
The Lancet (British edition), ISSN 0140-6736, 06/2004, Volume 363, Issue 9426, pp. 2022 - 2031
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Calcium Channel Blockers - adverse effects | Valsartan | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Sodium Chloride Symporter Inhibitors - therapeutic use | Angiotensin II Type 1 Receptor Blockers | Endpoint Determination | Diuretics | Female | Blood Pressure - drug effects | Double-Blind Method | Risk Factors | Valine - analogs & derivatives | Amlodipine - adverse effects | Treatment Outcome | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Tetrazoles - therapeutic use | Valine - therapeutic use | Aged | Tetrazoles - adverse effects | Valine - adverse effects | Hydrochlorothiazide - therapeutic use | Hypertension | Medical research | Side effects | Drug therapy | Drugs | Heart attacks | Heart surgery | Angioplasty | Antihypertensives | Risk | Cardiovascular disease | Evidence-based medicine | Blood | Randomization | Measurement techniques | Blood pressure | Heart diseases | Age | Heart failure | Edema | Stroke | Mortality | Medical treatment | Health risks | Angina pectoris | Patients | Coronary artery disease | Morbidity | Hypotheses | Coronary vessels | Diabetes | Cardiovascular diseases | Health risk assessment | Mercury | ACE inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2009, Volume 54, Issue 13, pp. 1154 - 1161
beta-blockers | heart rate | cardiovascular risk | hypertension | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Heart Rate | Europe | Humans | Middle Aged | Proportional Hazards Models | Coronary Disease - epidemiology | Coronary Disease - physiopathology | Hypertension - drug therapy | Male | Treatment Outcome | Antihypertensive Agents - therapeutic use | Bendroflumethiazide - therapeutic use | Hypertension - physiopathology | Amlodipine - therapeutic use | Coronary Disease - prevention & control | Atenolol - therapeutic use | Female | Aged | Perindopril - therapeutic use | Blood pressure | Heart attacks | Drug therapy | Cholesterol
Journal Article
BMC nephrology, ISSN 1471-2369, 01/2019, Volume 20, Issue 1, pp. 1 - 1
Metastatic renal cell carcinoma | Nephrotic syndrome | Pazopanib | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Lung Neoplasms - drug therapy | Humans | Carcinoma, Renal Cell - surgery | Hypertension - drug therapy | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Pancreaticoduodenectomy | Pneumonectomy | Protein Kinase Inhibitors - adverse effects | Dihydropyridines - adverse effects | Pancreatic Neoplasms - drug therapy | Angiogenesis Inhibitors - administration & dosage | Pancreatic Neoplasms - secondary | Lung Neoplasms - secondary | Antineoplastic Agents - adverse effects | Angiogenesis Inhibitors - therapeutic use | Everolimus - therapeutic use | Carcinoma, Renal Cell - drug therapy | Nephrotic Syndrome - chemically induced | Angiogenesis Inhibitors - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Pyrimidines - administration & dosage | Pancreatic Neoplasms - surgery | Nivolumab - therapeutic use | Combined Modality Therapy | Antihypertensive Agents - therapeutic use | Amlodipine - therapeutic use | Diabetic Nephropathies - complications | Dihydropyridines - therapeutic use | Edema - etiology | Protein Kinase Inhibitors - administration & dosage | Sulfonamides - therapeutic use | Sunitinib - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Carcinoma, Renal Cell - secondary | Kidney Failure, Chronic - complications | Pyrimidines - adverse effects | Hypertension - complications | Sulfonamides - adverse effects | Lung Neoplasms - surgery | Aged | Drug Substitution | Sulfonamides - administration & dosage | Antimitotic agents | Care and treatment | Albumin | B cells | Carcinoma, Renal cell | Metastasis | Antineoplastic agents | Health aspects | Cancer | Urine | Hypertension | Edema | Biomedical research | Family medical history | Patients | Cholesterol | Metastases | Proteins | Biopsy | Renal cell carcinoma | Kidney cancer | Antitumor activity | Blood pressure | Clinical medicine | Vascular endothelial growth factor | Drug dosages | Research centers | Index Medicus
Journal Article